/Investor DB

National Institutes of Health (NIH) — 2013 Investments

36 investments dated 2013 · listed companies and verified rows first · show all

Capricor Therapeuticscapricor.comin𝕏NASDAQ: CAPRSep 2013 · $8.4M

Capricor Therapeutics is a biotechnology company developing allogeneic cardiosphere-derived cell (CDC) and exosome-based therapeutics to treat serious diseases including Duchenne muscular dystrophy.

BiotechMedical DevicesLos Angeles, US

Linda Marban(President and Chief Executive Officer, Director)inLinda Marbán, Ph.D.(Chief Executive Officer and Director; co-founder of Capricor, Inc.)Rachel Smith(Executive Officer)inKaren Krasney(Executive Officer)inAnthony Bergmann(Executive Officer)Andrew Hamer(Executive Officer)in

Co-investorsBroadview Ventures

Savarasavarapharma.cominNASDAQ: SVRAMar 2013 · $4.5M

Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.

BiotechHealthtechMedical DevicesAustin, US

Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)inMike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)inSantosh J. Vetticaden(Executive Officer)Gregory D. Gorgas(Executive Officer)Patrick Keran(Executive Officer)

Co-investorsBain Capital Life SciencesCentral Texas Angel NetworkGreen Park & Golf VenturesKeiretsu ForumMoore Venture PartnersNew Enterprise Associates (NEA)

ACTUATED MEDICAL, INC.actuatedmedical.comin𝕏Jan 2013 · $35.8M

Actuated Medical develops a precision platform for guiding deep brain therapy delivery in patients with neurological and neurodegenerative disorders.

BiotechDeep TechHealthtechMedical DevicesBellefonte, US

Paul Frankhouser(Director)Robert Emert(Director)Maureen Mulvihill(Executive Officer, Director)

Akonni Biosystemsakonni.cominJun 2013 · $20.6M

Akonni Biosystems is a molecular diagnostics company that develops, manufactures, and sells integrated diagnostic systems along with nucleic acid sample preparation products.

BiotechFredrick, US

Charles Daitch(Executive Officer, Director)Jon Davis(Executive Officer)inGeorge Rudy(Executive Officer)Jennifer Reynolds(Executive Officer)inDarrell Chandler(Executive Officer)

BoardTom McMahon(Director)

AVATAR MEDICAL, LLCavatarbiotechnologies.comSep 2013 · $6.8M
BioMarck Pharmaceuticalsbiomarck.comAug 2013 · $6.5M

BiotechDurham, US

Robin Henning(Executive Officer)Brian Dickson(Executive Officer)inIndu Parikh(Executive Officer)

BoardThomas H. Roberg(Director)Kennedy C. O'Herron(Director)Craig A. Collard(Director)

BIOPICO SYSTEMS Inc.biopico.cominSep 2013 · $3.8M

BioPico develops pre-seeded tissue culture plates that enable reproducible studies of microvascular biology and cell interactions.

BiotechDeep TechHealthtechMedical Devices

Biospyder Technologies, Inc.biospyder.comSep 2013 · $17.4M

BioSpyder Technologies develops molecular biology instrumentation and services for life science research, particularly in gene expression analysis and genomics applications.

BiotechDeep TechHealthtechMedical Devices

Joel McComb(CEO and Co-Founder)Joanne Yeakley(VP, R&D and Co-Founder)Bruce Seligmann(Chief Scientific Officer)

BOLDER BIOTECHNOLOGY INCbolderbio.comMar 2013 · $23.4M

Bolder BioTechnology develops protein therapeutics using advanced protein engineering and bioconjugation to create longer-acting versions of FDA-approved protein drugs that require less frequent dosing than current treatments.

BiotechDeep TechHealthtechMedical DevicesBoulder, US

George (Joe) Cox, Ph.D.(Founder, President and Chief Scientific Officer)Joe Cox(President)

COLLABORATIVE DRUG DISCOVERY, INC.collaborativedrug.comin𝕏Aug 2013 · $14.4M

CDD provides software for collaborative research and discovery in biological and chemical sciences, serving scientists and organizations globally.

AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareSaaS

Barry Bunin(Founder & CEO)

Co-investorsBill & Melinda Gates Foundation

Delpordelpor.cominSep 2013 · $14.1M

Delpor develops subcutaneous implant devices that deliver therapeutic drugs over extended periods (6-12 months) for chronic condition treatment.

BiotechHealthtechMedical Devices

Co-investorsCloudStone CapitalKairos Venture Investments, LlcUlu Ventures

GigaGengigagen.comin𝕏Sep 2013 · $10.1M

GigaGen, a subsidiary of Grifols, develops recombinant polyclonal and monoclonal antibody therapies for immunodeficiencies, infectious diseases, transplant rejection, and cancer using single-cell discovery technologies.

BiotechDeep TechSouth San Francisco, US

David Johnson(Executive Officer, Director)inChuck Wilson(Director)Carter Keller(Director)

GLYCOSENSORS AND DIAGNOSTICS, LLClectenz.comin𝕏Sep 2013 · $11.1M

Lectenz Bio develops lectin-like binding proteins derived from inactivated glyco enzymes for use as research reagents in glycoscience applications.

AI & Machine LearningBiotechData & InfrastructureDeep TechSan Diego, US

Lori Yang(CEO, CSO, & Co-Founder)Robert J. Woods(President, Co-Founder, & Scientific Advisory Board Chair)Kausar N. Samli(Associate Founder)

Health Outcomes Inctelesage.comApr 2013 · $10.3M

TeleSage develops software tools for behavioral health outcomes tracking and research, serving clinicians and researchers worldwide.

Digital HealthHealthtechMedical DevicesMental Health

Dr. Benjamin Brodey(Founder)

IMMUNEXT PHARMACEUTICALSimmunext.comMar 2013 · $17.2M
INFINITE BIOMEDICAL TECHNOLOGIES, LLCi-biomed.comin𝕏Mar 2013 · $30.8M

IBT develops advanced prosthetic devices for people with upper limb differences, using proprietary control algorithms and flexible electronics technology.

BiotechDeep TechHealthtechMedical DevicesBaltimore, US

Nitish Thakor(Co-Founder, Professor of Biomedical Engineering)Ananth Natarajan(Co-Founder, Physician and Engineer)

INTEGRAL MOLECULAR INCintegralmolecular.cominDec 2013 · $28.8M

Integral Molecular is a biotechnology company developing innovative technologies and therapeutic antibodies targeting membrane proteins such as GPCRs, ion channels, transporters, and viral envelopes for drug discovery.

BiotechDeep TechPhiladelphia, US

Benjamin Doranz(Co-founder)

INTELLIGENT FIBER OPTIC SYSTEMS CORPifos.comAug 2013 · $6M
INTELLIGENT OPTICAL SYSTEMS, INC.intopsys.comSep 2013 · $20.3M
IS3D LLCcogenteducation.com𝕏Jul 2013 · $3.9M

Gizmos Investigations is an interactive online platform that places students in the role of STEM professionals solving real-world problems through guided inquiry activities.

AdTechAI & Machine LearningEdTech

JBS SCIENCE INCjbs-science.comAug 2013 · $9.6M

JBS Science develops liquid biopsy technology that detects circulating cell-free DNA in urine for cancer screening and management.

BiotechDigital HealthMedical Devices

KITWARE INCkitware.comin𝕏Sep 2013 · $45.2M

Kitware provides custom software solutions and advanced technical computing based on open source platforms, serving government agencies, commercial organizations, and research institutions.

AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareClifton Park, US

Lisa AvilaBill HoffmanWill SchroederKen MartinCharles Law

Michigan Critical Care Consultantsmc3corp.comSep 2013 · $29.4M

HealthtechDexter, US

Scott Merz(Executive Officer, Director)Catherine Schmidt(Executive Officer)Robert Bartlett(Director)Robert Foster(Executive Officer, Director)

BoardRio Foster(Director)Christopher Ball(Director)

MICROVI BIOTECH, INC.microvi.cominDec 2013 · $5.6M

Microvi is a biotechnology company that develops MicroNiche Engineering (MNE) biocatalyst systems for water and wastewater treatment, including nitrogen, nitrate, phosphorus, and hexavalent chromium removal, as well as industrial bioprocessing applications.

BiotechCleantechClimate TechHayward, US

Fatemeh Shirazi(CEO)inAli Dorri(Executive Officer)

BoardDr. Dirk Brusis(Director)C. Robert Kidder(Director)Hamid Rabie, Ph.D(Director)

Modulimmodulim.comin𝕏Jun 2013 · $9.9M

Modulim develops spatial frequency domain imaging (SFDI) technology that provides clinicians with microvascular and tissue oxygenation insights for the lower limb, supporting assessment of conditions such as diabetic circulatory complications.

Digital HealthHealthtechMedical DevicesIrvine, US

David J. Cuccia(Founder & Chief Technology Officer)inCharlie Huiner(President & Chief Executive Officer)inAmaan Mazhar(Chief Product Officer)in

Co-investorsFresenius Medical Care VenturesPangaea Ventures Us Inc.

MY COVERAGE PLAN INC.mycoverageplan.comSep 2013 · $2M
NAPROGENIX, INC.naprogenix.comSep 2013 · $17.5M

Co-investorsKeyhorse Capital

Orbis Biosciencesorbisbio.comin𝕏Sep 2013 · $6.2M

Lenexa, US

Cory Berkland(Executive Officer, Director)Maria Flynn(Executive Officer, Director)in

BoardBowman Fishback(Director)James Clarke(Director)

PAUL H BROOKES PUBLISHING CO., INC.brookespublishing.comin𝕏Dec 2013 · $2.4M

Brookes Publishing develops evidence-based books, assessments, and training materials for professionals serving children and families, with expertise in early childhood screening, child development, literacy, and inclusion.

EdTechHealthtechMedia & Entertainment

Jeff Brookes(Chief Executive Officer & President)Paul Brookes

PRIMITY BIO, INC.primitybio.comJul 2013 · $8.9M
SANARIA INC.sanaria.comin𝕏Aug 2013 · $90.6M

Sanaria develops malaria vaccines designed to prevent infection in at-risk populations worldwide, including pregnant women and children, with long-term goals of mass immunization campaigns and disease elimination.

BiotechHealthtechImpact & Social GoodMedical Devices

Stephen L. Hoffman(CEO)

Co-investorsBill & Melinda Gates Foundation

Sofie Biosciencessofiebio.comin𝕏Sep 2013 · $8.8M

BiotechCulver City, US

Michael Phelps(Director)Stan Berman(Executive Officer)inPatrick Phelps(Executive Officer, Director)inJohannes Czernin(Director)James Heath(Director)

BoardAjit Singh(Director)

Co-investorsCycad Group LLC

TECHSHOT, INC.techshot.comin𝕏Sep 2013 · $9.3M

Redwire is an integrated aerospace and defense company that builds space infrastructure, autonomous aircraft, and multi-domain systems for the space economy and for U.S. and allied military customers.

Defense TechHardwareSpace Tech

TREVIGEN, INC.trevigen.comSep 2013 · $10.2M
VENATORX PHARMACEUTICALS INCvenatorx.comAug 2013 · $30.8M

Developing ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral beta-lactam/beta-lactamase inhibitor combination for complicated urinary tract infections.

BiotechMalvern, US

Christopher J. Burns(Executive Officer, Director)Daniel C. Pevear(Executive Officer)Michael Diem(Director)Vincent J. Milano(Director)Ezra Felker(Executive Officer)Shelley Chu(Director)

Co-investorsAMR Action FundBioAdvanceForesite CapitalVersant Ventures

VORTANT TECHNOLOGIES LLCvortant.com𝕏Feb 2013 · $5.4M

Vortant Technologies is a design, technology, and software development firm that develops products and solutions through research and collaboration.

HardwareHealthtech

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.